| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 46.59 | 0.00 (0.00%) | 32.51 - 48.00 | 257.9 thousand (Below Avg) |
Market data as of 4:04PM 05/23/13. Quotes are delayed by at least 15 min.
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
05/20/2013 10:45 AM ET
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
05/17/2013 1:15 AM ET
AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
05/15/2013 6:21 PM ET